Please login to the form below
academia
This page shows the latest academia news and features for those working in and with pharma, biotech and healthcare.
Is competition the enemy of progress and collaboration the ally of success?
What exactly do I mean by collaboration? Collaboration with academia to elevate research capabilities.
Latest news
-
Novartis and Sanofi heads take on UK pharma leadership roles
world. “In the current Brexit environment, it is more important than ever to collaborate across government, businesses and academia to ensure that the UK can maintain its position as a leader
-
UCB looks to pipeline with five years left for twin blockbusters
drug discovery partnership with King’s College London university and its research teams working across academia and the NHS.
-
Merck & Co to buy IO specialists Immune Design for $300m
Big pharma, biotech and academia are zeroing in on a range of immune system mechanisms which could prove crucial to fighting diverse diseases.
-
UCB signs research deal with King’s College London
our world class expertise in translational research and clinical development at King’s with UCB’s long and successful track record of partnering with UK academia will yield successful benefits for
-
A genomics and digital-led NHS is possible – but investment in staff essential
It is logical that progress in meeting these challenges will be most effectively addressed through collaboration across industry, NHS and academia.
More from news
Approximately 7 fully matching, plus 135 partially matching documents found.
Latest Intelligence
-
The search for treatments for Parkinson’s disease
Dr Arthur Roach, director of research at the influential Parkinson’s UK charity, believes that genetic understanding is advancing at pace and that the collaborations between startups, academia, patient groups and ... is ignited by smaller biotechs,
-
GSK forges ahead with its dynamic COPD and asthma portfolio
But I think the work that we’ve done in collaboration with academia has demonstrated that there are various characteristics, called treatable traits, where you can identify patient groups that are
-
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
The driver is obviously the economic climate but the number of Chinese scientists returning every year with expertise from US and European academia and institutions is significant,” said Li Xiaofeng, manager
-
20 for 2020 – Five pharma leaders to watch in 2020
Questions have been raised, however, about his perceived lack of government experience, having spent most of his career in academia, although Hahn insists that isn’t an issue.
-
Integrating electronic health records into clinical trials
At the Leveraging EHR for Clinical Research Now! event, leaders from academia, companies including Amgen and AstraZeneca and the US Food and Drug Administration sought to identify the factors that are
More from intelligence
Approximately 1 fully matching, plus 43 partially matching documents found.
Latest appointments
-
New hires at Nanoform, Leo Pharma and Calliditas
Sandler comes to Nanoform with extensive experience in both industry and academia, particularly in pharmaceutical product development and material science.
-
Kevin Sin joins GSK
Gaining access to the best science and technologies across the world as well as establishing highly productive collaborations with academia and industry, play an important role in creating a world-class
-
Professor Carole Longson moves from NICE to the ABPI
experience, expertise and network in both industry and academia will enable the ABPI to work with our partners to further these objectives.”.
-
Orion appoints VP of oncology, R&D
I hope that my long background in the academia will help in the initiation of new research projects between Orion and the academia.
-
Storm Therapeutics strengthens its board
I look forward to working with the board to help guide Storm’s innovative research programmes, adding my experience from drug discovery in academia, pharma and biotech.”.
More from appointments
Approximately 1 fully matching, plus 18 partially matching documents found.
Latest from PMHub
-
Impetus Digital Fireside Chat with Ryan Wiley, President of Shift Health
We also talk about Ryan's shift from academia to consulting and the lessons learned along the way.
-
Porterhouse Medical Group strengthens its leadership team in the US
She brings a wealth of valuable experience to the Group having held scientific and strategic leadership roles in academia, corporate and global medical communications agencies.
-
Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.
companies as well as associated industries and academia.
-
Porterhouse Medical Group strengthens its US scientific team
His excellent heritage from academia, through agency, then pharma and back to the consulting and agency world – means that he has an excellent appreciation of client needs and how best an
-
The problem with the ‘recovery’ conversation in mental health
The narrative widely told in both the media and in academia typically describes an individual who has ‘recovered’ from a one-off episode of depression at some point in the past.
More from PMHub
Approximately 0 fully matching, plus 25 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- FDA hands BMS and bluebird bio a priority review for ide-cel
- 20 for 2020 – Five pharma companies to watch
- Q&A: Isabel Gibson
- Pearls of wisdom
- Using Artificial Intelligence to Transform Pharma
- Session 4: Systems Innovation Insight and Thinking
- Transforming Unstructured Healthcare Information into Real-World Evidence & Life Saving Insights
- UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
